James E Flynn Insider Trading $NTMD NITROMED INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Over the past year James E Flynn has been an insider in 10 companies. The total value of shares held by James E Flynn in these companies amounts to $12,414,862.

James E Flynn 10% Owner
Aclaris Therapeutics, Inc.
Director
Acutus Medical, Inc.
Director
AdaptHealth Corp.
10% Owner
Adverum Biotechnologies, Inc.
10% Owner
ALIMERA SCIENCES INC
Director, 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
Annexon, Inc.
10% Owner
ANTARES PHARMA, INC.
10% Owner
ARENA PHARMACEUTICALS INC
10% Owner
ARVINAS, INC.
10% Owner
aTYR PHARMA INC
10% Owner
Audentes Therapeutics, Inc.
10% Owner
Auspex Pharmaceuticals, Inc.
10% Owner
AVADEL PHARMACEUTICALS PLC
Director
AveXis, Inc.
10% Owner
Axogen, Inc.
10% Owner
Black Diamond Therapeutics, Inc.
10% Owner
Cabaletta Bio, Inc.
10% Owner
CAS MEDICAL SYSTEMS INC
10% Owner
CATALYST BIOSCIENCES, INC.
10% Owner
CONSTELLATION PHARMACEUTICALS INC
10% Owner
Cyclacel Pharmaceuticals, Inc.
10% Owner
CytomX Therapeutics, Inc.
Director
Deerfield Healthcare Technology Acquisitions Corp.
Director
DFP HEALTHCARE ACQUISITIONS CORP.
10% Owner
Dicerna Pharmaceuticals Inc
10% Owner
DUSA PHARMACEUTICALS INC
10% Owner
DYNAVAX TECHNOLOGIES CORP
10% Owner
Edgewise Therapeutics, Inc.
10% Owner
Editas Medicine, Inc.
10% Owner
eHealth, Inc.
10% Owner
EMAGEON INC
10% Owner
Fibrocell Science, Inc.
10% Owner
Frequency Therapeutics, Inc.
10% Owner
Generation Bio Co.
10% Owner
HI TECH PHARMACAL CO INC
10% Owner, Director
Homology Medicines, Inc.
10% Owner
INSPIRE PHARMACEUTICALS INC
10% Owner
Invuity, Inc.
10% Owner
ISTA PHARMACEUTICALS INC
10% Owner
Kiniksa Pharmaceuticals, Ltd.
10% Owner
Larimar Therapeutics, Inc.
10% Owner
Loxo Oncology, Inc.
10% Owner
LUMOS PHARMA, INC.
10% Owner
Mallinckrodt plc
10% Owner
MEDICINES CO /DE
10% Owner
Mirum Pharmaceuticals, Inc.
10% Owner
Neos Therapeutics, Inc.
10% Owner
NeurogesX Inc
10% Owner
NeuroMetrix, Inc.
10% Owner
NITROMED INC
10% Owner
Nkarta, Inc.
10% Owner
NxStage Medical, Inc.
Director
Oncorus, Inc.
10% Owner
PAR PHARMACEUTICAL COMPANIES, INC.
Director
Protara Therapeutics, Inc.
10% Owner
Recro Pharma, Inc.
10% Owner
REGENXBIO Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
RIGEL PHARMACEUTICALS INC
10% Owner
Schrodinger, Inc.
10% Owner
Shockwave Medical, Inc.
10% Owner
SteadyMed Ltd.
10% Owner
STREAMLINE HEALTH SOLUTIONS INC.
10% Owner
Syros Pharmaceuticals, Inc.
Director
Talon Therapeutics, Inc.
10% Owner
Terns Pharmaceuticals, Inc.
10% Owner
THIRD WAVE TECHNOLOGIES INC /WI
10% Owner
TriVascular Technologies, Inc.
10% Owner
Vanda Pharmaceuticals Inc.
10% Owner
VIA Pharmaceuticals, Inc.
10% Owner
Werewolf Therapeutics, Inc.
10% Owner
XENOPORT INC
10% Owner
XERIS PHARMACEUTICALS INC
$ 12414862 The total value of shares held by James E Flynn
Insider Rank

James E Flynn ranks 2,262 out of 350,000 insiders. Go to Insider Ranking to see more.

James E Flynn in NITROMED INC

Trading Symbol: NTMD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 46,085,133 shares
Latest Transaction: Apr 27 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of James E Flynn in NITROMED INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 27 2009NTMDNITROMED INCFlynn James E10% OwnerBuyP0.8646,085,13339,564,08746,085,1330 to 46.1 M
Apr 27 2009NTMDNITROMED INCFlynn James E10% OwnerSellJ0.863,281,4972,817,16503.3 M to 0 (-100.00 %)
Apr 27 2009NTMDNITROMED INCFlynn James E10% OwnerSellJ0.861,783,0191,530,72201.8 M to 0 (-100.00 %)
Dec 24 2008NTMDNITROMED INCFlynn James E10% OwnerSellS0.527,0813,6823,281,4973.3 M to 3.3 M (-0.22 %)
Dec 24 2008NTMDNITROMED INCFlynn James E10% OwnerSellS0.523,8462,0001,783,0171.8 M to 1.8 M (-0.22 %)
Dec 24 2008NTMDNITROMED INCFlynn James E10% OwnerSellS0.56291,512163,2473,288,5783.6 M to 3.3 M (-8.14 %)
Dec 24 2008NTMDNITROMED INCFlynn James E10% OwnerSellS0.56158,39288,7001,786,8631.9 M to 1.8 M (-8.14 %)
Aug 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.011,3171,3303,580,0903.6 M to 3.6 M (+0.04 %)
Aug 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.017187251,945,2551.9 M to 1.9 M (+0.04 %)
Aug 01 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.016,7626,8303,578,7733.6 M to 3.6 M (+0.19 %)
Aug 01 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.013,6883,7251,944,5371.9 M to 1.9 M (+0.19 %)
Aug 01 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.017,1187,1893,572,0113.6 M to 3.6 M (+0.20 %)
Aug 01 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.013,8823,9211,940,8491.9 M to 1.9 M (+0.20 %)
Jul 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.016356413,564,8933.6 M to 3.6 M (+0.02 %)
Jul 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.013453481,936,9671.9 M to 1.9 M (+0.02 %)
Jul 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0032,44132,4413,564,2583.5 M to 3.6 M (+0.92 %)
Jul 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0017,69917,6991,936,6221.9 M to 1.9 M (+0.92 %)
Jul 25 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.035,7915,9363,531,8173.5 M to 3.5 M (+0.16 %)
Jul 25 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.033,1593,2381,918,9231.9 M to 1.9 M (+0.16 %)
Jul 25 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0012,87612,8763,526,0263.5 M to 3.5 M (+0.37 %)
Jul 25 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.007,0247,0241,915,7641.9 M to 1.9 M (+0.37 %)
Jul 25 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.027,7337,8883,513,1503.5 M to 3.5 M (+0.22 %)
Jul 25 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.024,2194,3031,908,7401.9 M to 1.9 M (+0.22 %)
Jul 22 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0138,24938,6313,505,4173.5 M to 3.5 M (+1.10 %)
Jul 22 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0120,86821,0771,904,5211.9 M to 1.9 M (+1.11 %)
Jul 22 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0228,22228,7863,467,1683.4 M to 3.5 M (+0.82 %)
Jul 22 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0215,39715,7051,883,6531.9 M to 1.9 M (+0.82 %)
Jul 17 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.997707623,438,9463.4 M to 3.4 M (+0.02 %)
Jul 17 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.994204161,868,2561.9 M to 1.9 M (+0.02 %)
Jul 17 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.012722753,438,1763.4 M to 3.4 M (+0.01 %)
Jul 17 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.011481491,867,8361.9 M to 1.9 M (+0.01 %)
Jul 15 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0216,13716,4603,437,9043.4 M to 3.4 M (+0.47 %)
Jul 15 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.028,8038,9791,867,6881.9 M to 1.9 M (+0.47 %)
Jul 15 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9715,65015,1813,421,7673.4 M to 3.4 M (+0.46 %)
Jul 15 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.978,5388,2821,858,8851.9 M to 1.9 M (+0.46 %)
Jul 15 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9812,38012,1323,406,1173.4 M to 3.4 M (+0.36 %)
Jul 15 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.986,7546,6191,850,3471.8 M to 1.9 M (+0.37 %)
Jul 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9522,06120,9583,393,7373.4 M to 3.4 M (+0.65 %)
Jul 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9512,03511,4331,843,5931.8 M to 1.8 M (+0.66 %)
Jul 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.005,8055,7993,371,6763.4 M to 3.4 M (+0.17 %)
Jul 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.003,1653,1621,831,5581.8 M to 1.8 M (+0.17 %)
Jul 07 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9823,62923,1563,365,8713.3 M to 3.4 M (+0.71 %)
Jul 07 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9812,89112,6331,828,3931.8 M to 1.8 M (+0.71 %)
Jul 07 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.011951973,342,2423.3 M to 3.3 M (+0.01 %)
Jul 07 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.011051061,815,5021.8 M to 1.8 M (+0.01 %)
Jun 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9825,58125,0693,342,0473.3 M to 3.3 M (+0.77 %)
Jun 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP0.9813,89413,6161,815,3971.8 M to 1.8 M (+0.77 %)
Jun 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0327,14827,9623,316,4663.3 M to 3.3 M (+0.83 %)
Jun 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.0314,74715,1891,801,5031.8 M to 1.8 M (+0.83 %)
Jun 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.032,1512,2163,289,3183.3 M to 3.3 M (+0.07 %)
Jun 30 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.031,1671,2021,786,7561.8 M to 1.8 M (+0.07 %)
May 19 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1511,78313,5503,287,1673.3 M to 3.3 M (+0.36 %)
May 19 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.156,3997,3591,785,5891.8 M to 1.8 M (+0.36 %)
May 19 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1543,07949,5413,275,3843.2 M to 3.3 M (+1.33 %)
May 19 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1523,40026,9101,779,1901.8 M to 1.8 M (+1.33 %)
May 19 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1514,82717,0513,232,3053.2 M to 3.2 M (+0.46 %)
May 19 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.158,0539,2611,755,7901.7 M to 1.8 M (+0.46 %)
May 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1234,35038,4723,180,8993.1 M to 3.2 M (+1.09 %)
May 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1218,65920,8981,727,8701.7 M to 1.7 M (+1.09 %)
May 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1717,04319,9403,146,5493.1 M to 3.1 M (+0.54 %)
May 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.179,25710,8311,709,2111.7 M to 1.7 M (+0.54 %)
May 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2129,25835,4023,129,5063.1 M to 3.1 M (+0.94 %)
May 09 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2115,89119,2281,699,9541.7 M to 1.7 M (+0.94 %)
May 14 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1616,38319,0043,217,4783.2 M to 3.2 M (+0.51 %)
May 14 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.168,89910,3231,747,7371.7 M to 1.7 M (+0.51 %)
May 14 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.128,8789,9433,201,0953.2 M to 3.2 M (+0.28 %)
May 14 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.124,8215,4001,738,8381.7 M to 1.7 M (+0.28 %)
May 14 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.1411,31812,9033,192,2173.2 M to 3.2 M (+0.36 %)
May 14 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.146,1477,0081,734,0171.7 M to 1.7 M (+0.36 %)
May 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2648,92961,6513,100,2483.1 M to 3.1 M (+1.60 %)
May 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2626,57833,4881,684,0631.7 M to 1.7 M (+1.60 %)
May 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2745,33857,5793,051,3193 M to 3.1 M (+1.51 %)
May 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2724,62631,2751,657,4851.6 M to 1.7 M (+1.51 %)
May 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.2610,75713,5543,005,9813 M to 3 M (+0.36 %)
May 06 2008NTMDNITROMED INCFlynn James E10% OwnerBuyP1.265,8437,3621,632,8591.6 M to 1.6 M (+0.36 %)

Page:   1